{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T20:10:45Z","timestamp":1788725445836,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02343-1","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:16:49Z","timestamp":1788607009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Theaflavin attenuates atherosclerosis by targeting GSK-3\u03b2 to suppress pyroptosis and Promote Autophagy in macrophages"],"prefix":"10.1007","volume":"75","author":[{"given":"Sha","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3929-5040","authenticated-orcid":false,"given":"Zhengmin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185:1630\u201345. https:\/\/doi.org\/10.1016\/j.cell.2022.04.004.","journal-title":"Cell"},{"key":"2343_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbac103","volume":"10","author":"F Fang","year":"2023","unstructured":"Fang F, Xiao C, Li C, Liu X, Li S. Tuning macrophages for atherosclerosis treatment. Regen Biomater. 2023;10:rbac103. https:\/\/doi.org\/10.1093\/rb\/rbac103.","journal-title":"Regen Biomater"},{"key":"2343_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00666","volume":"10","author":"MC Flynn","year":"2019","unstructured":"Flynn MC, Pernes G, Lee MKS, Nagareddy PR, Murphy AJ. Monocytes, macrophages, and metabolic disease in atherosclerosis. Front Pharmacol. 2019;10:666. https:\/\/doi.org\/10.3389\/fphar.2019.00666.","journal-title":"Front Pharmacol"},{"key":"2343_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1161\/atvbaha.114.303565","volume":"35","author":"I Hilgendorf","year":"2015","unstructured":"Hilgendorf I, Swirski FK, Robbins CS. Monocyte fate in atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:272\u20139. https:\/\/doi.org\/10.1161\/atvbaha.114.303565.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2343_CR5","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/atvbaha.112.300173","volume":"33","author":"N Leitinger","year":"2013","unstructured":"Leitinger N, Schulman IG. Phenotypic polarization of macrophages in atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33:1120\u20136. https:\/\/doi.org\/10.1161\/atvbaha.112.300173.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2343_CR6","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.cell.2023.05.005","volume":"186","author":"B Sundaram","year":"2023","unstructured":"Sundaram B, Pandian N, Mall R, Wang Y, Sarkar R, Kim HJ, et al. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell. 2023;186:2783-2801.e2720. https:\/\/doi.org\/10.1016\/j.cell.2023.05.005.","journal-title":"Cell"},{"key":"2343_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040522","author":"AV Blagov","year":"2023","unstructured":"Blagov AV, Markin AM, Bogatyreva AI, Tolstik TV, Sukhorukov VN, Orekhov AN. The role of macrophages in the pathogenesis of atherosclerosis. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12040522.","journal-title":"Cells"},{"key":"2343_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.824165","volume":"10","author":"D Song","year":"2022","unstructured":"Song D, Li M, Yu X, Wang Y, Fan J, Yang W, et al. The molecular pathways of pyroptosis in atherosclerosis. Front Cell Dev Biol. 2022;10:824165. https:\/\/doi.org\/10.3389\/fcell.2022.824165.","journal-title":"Front Cell Dev Biol"},{"key":"2343_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.657486","volume":"12","author":"M Jiang","year":"2021","unstructured":"Jiang M, Sun X, Liu S, Tang Y, Shi Y, Bai Y, et al. Caspase-11-gasdermin D-mediated pyroptosis is involved in the pathogenesis of atherosclerosis. Front Pharmacol. 2021;12:657486. https:\/\/doi.org\/10.3389\/fphar.2021.657486.","journal-title":"Front Pharmacol"},{"key":"2343_CR10","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/atvbaha.115.307312","volume":"36","author":"K Rajam\u00e4ki","year":"2016","unstructured":"Rajam\u00e4ki K, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Risco A, Tuimala J, Nurmi K, Cuenda A, et al. p38\u03b4 MAPK: a novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis. Arterioscler Thromb Vasc Biol. 2016;36:1937\u201346. https:\/\/doi.org\/10.1161\/atvbaha.115.307312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2343_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41569-023-00957-0","volume":"21","author":"GRY De Meyer","year":"2024","unstructured":"De Meyer GRY, Zurek M, Puylaert P, Martinet W. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. Nat Rev Cardiol. 2024;21:312\u201325. https:\/\/doi.org\/10.1038\/s41569-023-00957-0.","journal-title":"Nat Rev Cardiol"},{"key":"2343_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cmet.2012.02.011","volume":"15","author":"B Razani","year":"2012","unstructured":"Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab. 2012;15:534\u201344. https:\/\/doi.org\/10.1016\/j.cmet.2012.02.011.","journal-title":"Cell Metab"},{"key":"2343_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40216-x","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Vandestienne M, Lavillegrand JR, Joffre J, Santos-Zas I, Lavelle A, et al. Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy. Nat Commun. 2023;14:4622. https:\/\/doi.org\/10.1038\/s41467-023-40216-x.","journal-title":"Nat Commun"},{"key":"2343_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28155871","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Hu K, Li D, Guo H, Xie Z. Microbial-transferred metabolites of black tea theaflavins by human gut microbiota and their impact on antioxidant capacity. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28155871.","journal-title":"Molecules"},{"key":"2343_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.14712\/fb2007053050164","volume":"53","author":"F Cai","year":"2007","unstructured":"Cai F, Li C, Wu J, Min Q, Ouyang C, Zheng M, et al. Modulation of the oxidative stress and nuclear factor kappaB activation by theaflavin 3,3\u2019-gallate in the rats exposed to cerebral ischemia-reperfusion. Folia biologica. 2007;53:164\u201372.","journal-title":"Folia biologica"},{"key":"2343_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3892\/ijo.2015.3257","volume":"48","author":"Y Gao","year":"2016","unstructured":"Gao Y, Rankin GO, Tu Y, Chen YC. Theaflavin-3, 3\u2019-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways. Int J Oncol. 2016;48:281\u201392. https:\/\/doi.org\/10.3892\/ijo.2015.3257.","journal-title":"Int J Oncol"},{"key":"2343_CR17","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1021\/jf000066d","volume":"48","author":"JK Lin","year":"2000","unstructured":"Lin JK, Chen PC, Ho CT, Lin-Shiau SY. Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3\u2019-digallate, (-)-epigallocatechin-3-gallate, and propyl gallate. J Agric Food Chem. 2000;48:2736\u201343. https:\/\/doi.org\/10.1021\/jf000066d.","journal-title":"J Agric Food Chem"},{"key":"2343_CR18","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1002\/ptr.7064","volume":"35","author":"J Zeng","year":"2021","unstructured":"Zeng J, Deng Z, Zou Y, Liu C, Fu H, Gu Y, et al. Theaflavin alleviates oxidative injury and atherosclerosis progress via activating microRNA-24-mediated Nrf2\/HO-1 signal. Phytother Res. 2021;35:3418\u201327. https:\/\/doi.org\/10.1002\/ptr.7064.","journal-title":"Phytother Res"},{"key":"2343_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.861319","volume":"13","author":"Y Wu","year":"2022","unstructured":"Wu Y, Chen M, Chen Z, Shu J, Zhang L, Hu J, et al. Theaflavin-3,3\u2019-digallate from black tea inhibits neointima formation through suppression of the PDGFR\u03b2 pathway in vascular smooth muscle cells. Front Pharmacol. 2022;13:861319. https:\/\/doi.org\/10.3389\/fphar.2022.861319.","journal-title":"Front Pharmacol"},{"key":"2343_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1348238","volume":"14","author":"Q Yang","year":"2023","unstructured":"Yang Q, Saaoud F, Lu Y, Pu Y, Xu K, Shao Y, et al. Innate immunity of vascular smooth muscle cells contributes to two-wave inflammation in atherosclerosis, twin-peak inflammation in aortic aneurysms and trans-differentiation potential into 25 cell types. Front Immunol. 2023;14:1348238. https:\/\/doi.org\/10.3389\/fimmu.2023.1348238.","journal-title":"Front Immunol"},{"key":"2343_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-023-00451-9","volume":"12","author":"L Qi","year":"2023","unstructured":"Qi L, Pan X, Chen X, Liu P, Chen M, Zhang Q, et al. COX-2\/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma. Oncogenesis. 2023;12:5. https:\/\/doi.org\/10.1038\/s41389-023-00451-9.","journal-title":"Oncogenesis"},{"key":"2343_CR22","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:D1202-1213. https:\/\/doi.org\/10.1093\/nar\/gkv951.","journal-title":"Nucleic Acids Res"},{"key":"2343_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334.","journal-title":"J Comput Chem"},{"key":"2343_CR24","unstructured":"Delano, WL. PyMOL: An Open-Source Molecular Graphics Tool. 2002."},{"issue":"1","key":"2343_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"T Hou","year":"2011","unstructured":"Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM\/PBSA and MM\/GBSA methods. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model. 2011;51(1):69\u201382. https:\/\/doi.org\/10.1021\/ci100275a.","journal-title":"J Chem Inf Model"},{"key":"2343_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449\u201361. https:\/\/doi.org\/10.1517\/17460441.2015.1032936.","journal-title":"Expert Opin Drug Discov"},{"key":"2343_CR27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/jcc.21372","volume":"31","author":"G Rastelli","year":"2010","unstructured":"Rastelli G, Del Rio A, Degliesposti G, Sgobba M. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J Comput Chem. 2010;31:797\u2013810. https:\/\/doi.org\/10.1002\/jcc.21372.","journal-title":"J Comput Chem"},{"key":"2343_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4354786","author":"H Xu","year":"2019","unstructured":"Xu H, Jiang J, Chen W, Li W, Chen Z. Vascular macrophages in atherosclerosis. J Immunol Res. 2019. https:\/\/doi.org\/10.1155\/2019\/4354786.","journal-title":"J Immunol Res"},{"key":"2343_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13:709\u201321. https:\/\/doi.org\/10.1038\/nri3520.","journal-title":"Nat Rev Immunol"},{"key":"2343_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.809955","volume":"9","author":"L Lin","year":"2021","unstructured":"Lin L, Zhang MX, Zhang L, Zhang D, Li C, Li YL. Autophagy, pyroptosis, and ferroptosis: new regulatory mechanisms for atherosclerosis. Front Cell Dev Biol. 2021;9:809955. https:\/\/doi.org\/10.3389\/fcell.2021.809955.","journal-title":"Front Cell Dev Biol"},{"key":"2343_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cca.2017.11.005","volume":"476","author":"YJ Xu","year":"2018","unstructured":"Xu YJ, Zheng L, Hu YW, Wang Q. Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta. 2018;476:28\u201337. https:\/\/doi.org\/10.1016\/j.cca.2017.11.005.","journal-title":"Clin Chim Acta"},{"key":"2343_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.652963","volume":"12","author":"Z Qian","year":"2021","unstructured":"Qian Z, Zhao Y, Wan C, Deng Y, Zhuang Y, Xu Y, et al. Pyroptosis in the initiation and progression of atherosclerosis. Front Pharmacol. 2021;12:652963. https:\/\/doi.org\/10.3389\/fphar.2021.652963.","journal-title":"Front Pharmacol"},{"key":"2343_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101781","volume":"69","author":"SO Vasudevan","year":"2023","unstructured":"Vasudevan SO, Behl B, Rathinam VA. Pyroptosis-induced inflammation and tissue damage. Semin Immunol. 2023;69:101781. https:\/\/doi.org\/10.1016\/j.smim.2023.101781.","journal-title":"Semin Immunol"},{"key":"2343_CR34","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1002\/jcp.30366","volume":"236","author":"B He","year":"2021","unstructured":"He B, Nie Q, Wang F, Han Y, Yang B, Sun M, et al. Role of pyroptosis in atherosclerosis and its therapeutic implications. J Cell Physiol. 2021;236:7159\u201375. https:\/\/doi.org\/10.1002\/jcp.30366.","journal-title":"J Cell Physiol"},{"key":"2343_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav1447","author":"J Lieberman","year":"2019","unstructured":"Lieberman J, Wu H, Kagan JC. Gasdermin D activity in inflammation and host defense. Sci Immunol. 2019. https:\/\/doi.org\/10.1126\/sciimmunol.aav1447.","journal-title":"Sci Immunol"},{"key":"2343_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ctm2.13","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu X, Shi H, Yu Y, Yu Y, Li M, et al. NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases. Clin Transl Med. 2020;10:91\u2013106. https:\/\/doi.org\/10.1002\/ctm2.13.","journal-title":"Clin Transl Med"},{"key":"2343_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejphar.2016.11.027","volume":"794","author":"Y Wu","year":"2017","unstructured":"Wu Y, Jin F, Wang Y, Li F, Wang L, Wang Q, et al. In vitro and in vivo anti-inflammatory effects of theaflavin-3,3\u2019-digallate on lipopolysaccharide-induced inflammation. Eur J Pharmacol. 2017;794:52\u201360. https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.027.","journal-title":"Eur J Pharmacol"},{"key":"2343_CR38","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41401-023-01105-7","volume":"44","author":"SY Chen","year":"2023","unstructured":"Chen SY, Li YP, You YP, Zhang HR, Shi ZJ, Liang QQ, et al. Theaflavin mitigates acute gouty peritonitis and septic organ injury in mice by suppressing NLRP3 inflammasome assembly. Acta Pharmacol Sin. 2023;44:2019\u201336. https:\/\/doi.org\/10.1038\/s41401-023-01105-7.","journal-title":"Acta Pharmacol Sin"},{"key":"2343_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10495-024-02029-1","volume":"30","author":"H Bao","year":"2025","unstructured":"Bao H, Wang C, Jin Y, Meng Q, Wu J, Liu Q, et al. The contributory role of GSK3\u03b2 in hypertension exacerbating atherosclerosis by regulating the OMA1\/PGC1\u03b1 pathway. Apoptosis. 2025;30:117\u201330. https:\/\/doi.org\/10.1007\/s10495-024-02029-1.","journal-title":"Apoptosis"},{"key":"2343_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174830","volume":"920","author":"SH Wang","year":"2022","unstructured":"Wang SH, Cui LG, Su XL, Komal S, Ni RC, Zang MX, et al. GSK-3\u03b2-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts. Eur J Pharmacol. 2022;920:174830. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174830.","journal-title":"Eur J Pharmacol"},{"key":"2343_CR41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1021\/acscentsci.2c01424","volume":"9","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang M, Huo XK, Ning J, Yu ZL, Morisseau C, et al. Macrophage inactivation by small molecule wedelolactone via targeting sEH for the treatment of LPS-induced acute lung injury. ACS Cent Sci. 2023;9:440\u201356. https:\/\/doi.org\/10.1021\/acscentsci.2c01424.","journal-title":"ACS Cent Sci"},{"key":"2343_CR42","doi-asserted-by":"publisher","first-page":"45937","DOI":"10.1074\/jbc.M306268200","volume":"278","author":"R Bhat","year":"2003","unstructured":"Bhat R, Xue Y, Berg S, Hellberg S, Orm\u00f6 M, Nilsson Y, et al. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem. 2003;278:45937\u201345. https:\/\/doi.org\/10.1074\/jbc.M306268200.","journal-title":"J Biol Chem"},{"key":"2343_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087541","author":"B Balboni","year":"2023","unstructured":"Balboni B, Masi M, Rocchia W, Girotto S, Cavalli A. GSK-3\u03b2 allosteric inhibition: a dead end or a new pharmacological frontier? Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24087541.","journal-title":"Int J Mol Sci"},{"key":"2343_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409015","volume":"36","author":"M Liang","year":"2024","unstructured":"Liang M, Wang Q, Zhang S, Lan Q, Wang R, Tan E, et al. Polypyridiniums with inherent autophagy-inducing activity for atherosclerosis treatment by intracellularly co-delivering two antioxidant enzymes. Adv Mater. 2024;36:e2409015. https:\/\/doi.org\/10.1002\/adma.202409015.","journal-title":"Adv Mater"},{"key":"2343_CR45","doi-asserted-by":"publisher","first-page":"114333","DOI":"10.1016\/j.biopha.2023.114333","volume":"161","author":"G Hu","year":"2023","unstructured":"Hu G, Yuan Z, Wang J. Autophagy inhibition and ferroptosis activation during atherosclerosis: Hypoxia-inducible factor 1\u03b1 inhibitor PX-478 alleviates atherosclerosis by inducing autophagy and suppressing ferroptosis in macrophages. Biomed & pharmacotherapy = Biomed & pharmacotherapie. 2023;161:114333. https:\/\/doi.org\/10.1016\/j.biopha.2023.114333.","journal-title":"Biomed & pharmacotherapy = Biomed & pharmacotherapie"},{"key":"2343_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307206","volume":"11","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wang Y, Zhen Z, Li J, Su J, Wu C. mTORC1 mediates biphasic mechano-response to orchestrate adhesion-dependent cell growth and anoikis resistance. Adv Sci. 2024;11:e2307206. https:\/\/doi.org\/10.1002\/advs.202307206.","journal-title":"Adv Sci"},{"key":"2343_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020258","author":"J Nah","year":"2022","unstructured":"Nah J, Sung EA, Zhai P, Zablocki D, Sadoshima J. Tfeb-mediated transcriptional regulation of autophagy induces autosis during ischemia\/reperfusion in the heart. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11020258.","journal-title":"Cells"},{"key":"2343_CR48","doi-asserted-by":"publisher","first-page":"117573","DOI":"10.1016\/j.biopha.2024.117573","volume":"180","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yuan T, He L, Huang J, Wilfred N, Yang W, et al. Melittin treatment suppressed malignant NSCLC progression through enhancing CTSB-mediated hyperautophagy. Biomedicine & pharmacotherapy Biomedecine & pharmacotherapie. 2024;180:117573. https:\/\/doi.org\/10.1016\/j.biopha.2024.117573.","journal-title":"Biomedicine & pharmacotherapy Biomedecine & pharmacotherapie"},{"key":"2343_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00018-024-05274-4","volume":"81","author":"L Gallwitz","year":"2024","unstructured":"Gallwitz L, Bleibaum F, Voss M, Schweizer M, Spengler K, Winter D, et al. Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis. Cellular and molecular life sciences\u202f: CMLS. 2024;81:227. https:\/\/doi.org\/10.1007\/s00018-024-05274-4.","journal-title":"Cellular and molecular life sciences : CMLS"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02343-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T20:02:13Z","timestamp":1788724933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02343-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02343-1","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent has been obtained from the patient(s) to publish this paper.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. All clinical samples used in this study were obtained from our Affiliated Hospital, with the procedure approved by the hospital\u2019s Ethics Committee (2024ER23-1); The mouse experiment was approved by the Institutional Animal Care and Use committees of NSMC ([2023]091).","order":3,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"196"}}